Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 14/20 | 1.00 |
| ▸ | AGXT | P21549 | 8/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | PNMT | P11086 | 1/20 | 0.59 |
| ▸ | MAOB | P27338 | 2/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30079884 | 1.00 | IDO1 (1.00) | IDO1AGXTCYP3A4PNMTMAOB | |
| Hydrochloric Acid SCHEMBL1715226 | 0.98 | IDO1 (1.00) | IDO1AGXTCYP3A4PNMTMAOB | |
| SCHEMBL437710 | 0.84 | IDO1 (0.71) | IDO1AGXTCYP3A4 | |
| SCHEMBL28404628 | 0.82 | CYP3A4 (0.69) | IDO1AGXTCYP3A4PNMTMAOB | |
| SCHEMBL10866481 | 0.82 | CYP3A4 (0.69) | IDO1AGXTCYP3A4PNMTMAOB | |
| SCHEMBL1855225 | 0.80 | CYP3A4 (0.67) | IDO1AGXTCYP3A4PNMTMAOB | |
| SCHEMBL1521149 | 0.79 | AGXT (0.73) | IDO1AGXTCYP3A4TAAR1 | |
| SCHEMBL4950985 | 0.78 | CYP3A4 (0.64) | IDO1AGXTCYP3A4PNMTMAOB | |
| SCHEMBL7040986 | 0.78 | CYP3A4 (0.64) | IDO1AGXTCYP3A4PNMTMAOB | |
| SCHEMBL7958908 | 0.78 | CYP3A4 (0.64) | IDO1AGXTCYP3A4PNMTMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11661436-B2 | Method for preparing 3′-o-amino-2′-deoxyribonucleoside-5′-triphosphates | DNA SCRIPT SAS (FR) | 2023-05-30 | — | — | US | claimed |
| EP-4126895-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA Script (FR) | 2023-02-08 | — | — | EP | claimed |
| CN-115362161-A | Process for preparing 3' -O-amino-2 ' -deoxyribonucleoside-5 ' -triphosphates | DNA斯克瑞普特公司 | 2022-11-18 | — | — | CN | claimed |
| WO-2021198040-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES. | DNA SCRIPT (FR) | 2021-10-07 | — | — | WO | claimed |
| US-20210300961-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA SCRIPT SAS (FR) | 2021-09-30 | — | — | US | claimed |
| EP-2697193-B1 | SUBSTITUTED 5-(CYCLOHEX-2-EN-1-YL)-PENTA-2,4-DIENES AND 5-(CYCLOHEX-2-EN-1-YL)-PENT-2-EN-4-INES AS ACTIVE AGENTS AGAINST ABIOTIC STRESS IN PLANTS | BAYER IP GMBH (DE) | 2016-07-06 | — | — | EP | claimed |
| EP-2227233-B1 | IDO INHIBITORS | NEWLINK GENETICS (US) | 2013-02-13 | — | — | EP | claimed |
| US-20110053941-A1 | IDO Inhibitors | NEWLINK GENETICS (US) | 2011-03-03 | — | — | US | claimed |
| EP-2227233-A2 | IDO INHIBITORS | Newlink Genetics (US) | 2010-09-15 | — | — | EP | claimed |
| WO-2009073620-A2 | IDO INHIBITORS | NEWLINK GENETICS (US) | 2009-06-11 | — | — | WO | claimed |
| US-11661436-B2 | Method for preparing 3′-o-amino-2′-deoxyribonucleoside-5′-triphosphates | DNA SCRIPT SAS (FR) | 2023-05-30 | — | — | US | disclosed |
| EP-4126895-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA Script (FR) | 2023-02-08 | — | — | EP | disclosed |
| CN-115362161-A | Process for preparing 3' -O-amino-2 ' -deoxyribonucleoside-5 ' -triphosphates | DNA斯克瑞普特公司 | 2022-11-18 | — | — | CN | disclosed |
| WO-2021198040-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES. | DNA SCRIPT (FR) | 2021-10-07 | — | — | WO | disclosed |
| US-20210300961-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DNA SCRIPT SAS (FR) | 2021-09-30 | — | — | US | disclosed |
| US-20110053941-A1 | IDO Inhibitors | NEWLINK GENETICS (US) | 2011-03-03 | — | — | US | disclosed |
| US-20080234298-A1 | ANTIFOLATE AGENT COMBINATIONS IN THE TREATMENT OF CANCER | TRACON PHARMACEUTICALS, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-6562792-B1 | Hygromycin derivatives | PFIZER INC. | 2003-05-13 | — | — | US | disclosed |
| EP-1224197-A1 | HYGROMYCIN DERIVATIVES | Pfizer Products Inc. (US) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001030795-A1 | HYGROMYCIN DERIVATIVES | PFIZER PRODUCTS INC. (US) | 2001-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210300961-A1 | METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES | DUT, RNMT, NUDT1 | IDO1 997/4885AGXT 971/4885CYP3A4 825/4885 |
| US-11661436-B2 | Method for preparing 3′-o-amino-2′-deoxyribonucleoside-5′-triphosphates | DUT, RNMT, NUDT1 | IDO1 984/4885AGXT 924/4885CYP3A4 879/4885 |
| US-20110053941-A1 | IDO Inhibitors | IDO1, IDO2, INMT | IDO1 1/4885AGXT 365/4885CYP3A4 413/4885 |
| US-20080234298-A1 | ANTIFOLATE AGENT COMBINATIONS IN THE TREATMENT OF CANCER | FEN1, UNG, FOLR1 | IDO1 3342/4885AGXT 550/4885CYP3A4 4517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.